Jun Yoon
Financieel Directeur/CFO bij STRUCTURE THERAPEUTICS INC.
Vermogen: 30 M $ op 31-05-2024
Actieve functies van Jun Yoon
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| STRUCTURE THERAPEUTICS INC. | Financieel Directeur/CFO | 01-05-2022 | - |
| Directeur/Bestuurslid | 01-05-2022 | 01-01-2023 | |
Shanghai ShouTi Biotechnology Co., Ltd.
 Shanghai ShouTi Biotechnology Co., Ltd. BiotechnologyHealth Technology Part of Structure Therapeutics, Inc., Shanghai ShouTi Biotechnology Co., Ltd. develops biotechnologies. The company is based in Shanghai, China. The CEO of the Chinese company is Xi Chen Lin. | Directeur/Bestuurslid | - | - |
| Operationeel Directeur | - | - |
Loopbaan van Jun Yoon
Eerdere bekende functies van Jun Yoon
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Cellerant Therapeutics, Inc.
 Cellerant Therapeutics, Inc. Medical SpecialtiesHealth Technology Cellerant Therapeutics, Inc. develops stem cell-based cellular and antibody therapeutics for blood disorders and cancer. The firm focuses on curative therapies for seriously ill patients and is developing a cell-based medicine as a treatment for chemotherapy and radiation-induced neutropenia as well as for Acute Radiation Syndrome. The company was founded by Irving L. Weissman in 2003 and is headquartered in San Carlos, CA. | Corporate Officer/Principal | 01-05-2010 | 01-01-2016 |
| VIA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-08-2004 | 01-03-2010 |
Syrrx, Inc.
 Syrrx, Inc. Pharmaceuticals: MajorHealth Technology Syrrx, Inc. used to develops drugs. Its focus was on creating novel therapies for cancer, metabolic diseases and inflammation. The company was the technology leader in the field of structural proteomics, the process of generating protein structures from genetic information. It was headquartered in San Diego, CA | Corporate Officer/Principal | 01-07-2000 | 01-10-2002 |
Opleiding van Jun Yoon
| University of California | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 6 |
| China | 2 |
Operationeel
| Corporate Officer/Principal | 3 |
| Director/Board Member | 2 |
| Director of Finance/CFO | 1 |
Sectoraal
| Health Technology | 5 |
| Commercial Services | 2 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| STRUCTURE THERAPEUTICS INC. | Commercial Services |
| VIA PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Cellerant Therapeutics, Inc.
Cellerant Therapeutics, Inc. Medical SpecialtiesHealth Technology Cellerant Therapeutics, Inc. develops stem cell-based cellular and antibody therapeutics for blood disorders and cancer. The firm focuses on curative therapies for seriously ill patients and is developing a cell-based medicine as a treatment for chemotherapy and radiation-induced neutropenia as well as for Acute Radiation Syndrome. The company was founded by Irving L. Weissman in 2003 and is headquartered in San Carlos, CA. | Health Technology |
Syrrx, Inc.
Syrrx, Inc. Pharmaceuticals: MajorHealth Technology Syrrx, Inc. used to develops drugs. Its focus was on creating novel therapies for cancer, metabolic diseases and inflammation. The company was the technology leader in the field of structural proteomics, the process of generating protein structures from genetic information. It was headquartered in San Diego, CA | Health Technology |
Shanghai ShouTi Biotechnology Co., Ltd.
Shanghai ShouTi Biotechnology Co., Ltd. BiotechnologyHealth Technology Part of Structure Therapeutics, Inc., Shanghai ShouTi Biotechnology Co., Ltd. develops biotechnologies. The company is based in Shanghai, China. The CEO of the Chinese company is Xi Chen Lin. | Health Technology |
